Xconomy National

Archives

by in

Entry	Author	Date	Location
AVI Biopharma Axes 28% of Workforce, After Missing Out on Flu Contract	Luke Timmerman	12/12/11	Seattle
AVI Starts Duchenne Trial	Luke Timmerman	08/15/11	Seattle
ASCO Wrap-Up, Pathway Medical Grinds It Out, Gates Foundation’s New Digs, & More in Seattle-Area Life Sciences News	Luke Timmerman	06/09/11	Seattle
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company	Luke Timmerman	06/02/11	Seattle
Regulus Names Chief Scientist	Luke Timmerman	04/18/11	San Diego
Omeros Flunks Pivotal Trials, Dendreon’s Shareholder Hubbub, AVI Biopharma Nabs $30M, & More Seattle-Area Life Sciences News	Luke Timmerman	04/07/11	Seattle
AVI Biopharma Adds $30M	Luke Timmerman	04/01/11	Seattle
Dendreon Wins Medicare Coverage, Clarisonic Tops $100M in Sales, Sage Partners Up, & More Seattle-Area Life Sciences News	Luke Timmerman	03/31/11	Seattle
AVI Biopharma Adds Chief Scientist	Luke Timmerman	03/28/11	Seattle
The Immunex Alumni, Hood Wins Russ Prize, Williams Grabs Biogen Gig, & More Seattle-Area Life Sciences News	Luke Timmerman	01/06/11	Seattle
AVI Partners With Karolinska	Luke Timmerman	01/05/11	Seattle
Adaptive TCR Seeks to Dominate New Industry, Ultrasound on an iPhone, AVI Names CEO, & More Seattle-Area Life Sciences News	Luke Timmerman	12/16/10	Seattle
AVI Names New CEO	Luke Timmerman	12/13/10	Seattle
Acceleron Snags $498M Deal With Shire to Develop Muscular Dystrophy Drugs	Luke Timmerman	09/09/10	Boston
Tekmira and AVI Win Ebola Deals, Mirador’s Idea to Prevent Hospital Errors, Tom Ranken’s New Mission, & More Seattle-Area Life Sciences News	Luke Timmerman	07/22/10	Seattle
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News	Luke Timmerman	06/11/10	Seattle
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News	Luke Timmerman	04/22/10	Seattle
AVI Biopharma Ousts CEO Les Hudson in Boardroom Coup	Luke Timmerman	04/21/10	Seattle
Cell Therapeutics Nears Judgment Day, AVI Biopharma Awaits Results, HemaQuest Gets $6M & More Seattle-Area Life Sciences News	Luke Timmerman	02/04/10	Seattle
AVI Biopharma Eagerly Awaits Data on Muscular Dystrophy Drug	Luke Timmerman	02/01/10	Seattle
A Brief Year-End Review of Seattle Biotech	Stewart Lyman	12/31/09	Seattle
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News	Luke Timmerman	12/24/09	Seattle
AVI Biopharma Drug Shows Hint of Effect Against Muscular Dystrophy In Small Study	Luke Timmerman	12/22/09	Seattle
Six Red Flags to Watch Out For in a Biotech, From Dendreon Co-Founder Chris Henney	Luke Timmerman	10/15/09	Seattle
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News	Luke Timmerman	10/08/09	Seattle
AVI Nabs $11.5M Defense Contract	Luke Timmerman	10/05/09	Seattle
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News	Luke Timmerman	10/01/09	Seattle
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009	Luke Timmerman	09/22/09	Seattle
Trubion Scores $20M, Archus Shuts Down, AVI Biopharma’s Hope for Muscular Dystrophy, & More Seattle-Area Life Sciences News	Luke Timmerman	09/03/09	Seattle
AVI Offers Glimmer of Hope for Muscular Dystrophy, Says UW Neuroscientist Jeff Chamberlain	Luke Timmerman	09/01/09	Seattle
Page 1 of 2	next page »